Better diagnostic tests needed to guide HER2 breast cancer treatment, study suggests

[News]

A new study by researchers at Yale Cancer Center shows using current standard human epidermal growth factor receptor 2 (HER2) assays as a diagnostic test may result in a mis-assignment of patients for treatment for breast cancer with a promising new drug.

More... (https://www.news-medical.net/news/20220203/Better-diagnostic-tests-needed-to-guide-HER2-breast-cancer-treatment-study-suggests.aspx)